Zhenghe·The 18th CBIC Cell Biology Industry Conference
and the 9th International Conference on Cell Therapy and Regenerative Medicine
I. Introduction
Exploring the mysteries of life and ushering in a new era for cells. In the rapid development of life sciences, cell biotechnology is reshaping the future of medicine with unprecedented depth and breadth, bringing revolutionary hope to human health. The 18th CBIC Cell Biology Industry Conference and the 9th International Conference on Cell Therapy and Regenerative Medicine, hosted by Zhenghe Exhibition Group, will be held in Hangzhou from September 3-4 2026. ( Beijing, November 19-21，2026 )
The conference will focus on cutting-edge fields such as cell therapy, stem cell research and applications, exosome technology, regenerative medicine, anti-aging medicine, organoid models, tumor immune cell therapy, and CGT (cell and gene therapy) drug development and clinical translation. We will share and present diverse perspectives on process development, technological innovation, clinical applications, drug R&D, industrial transformation, commercialization strategies, and laws and regulations. We invite you to explore new trends and opportunities in cell biology and promote high-quality development in the industry!
II. Audience
01. Clinicians and physician assistants in public and private hospitals, including hematology, cell therapy, immunotherapy, clinical laboratory, oncology, orthopedics, dermatology, and other clinical departments;
02. Professors, scholars, and researchers at major research universities and regulatory agencies;
03. Exosome researchers, physicians, and nurses in aesthetic medicine clinics;
04. Practitioners in regenerative medicine, health management organizations, rehabilitation centers, physical examination centers, and anti-aging clinics;
05. CGT pharmaceutical companies, CROs, CMOs, ACRPs, cell banks, animal research institutes, key laboratories, and CMC development personnel;
06. Heads of cell-based biopharmaceutical and chemical drug suppliers, agents, investment and financing institutions, and other organizations;
07. Professionals in the healthcare and anti-aging fields seeking trading partners and business opportunities;
08. Gene editing tool developers, gene therapy R&D companies; AI and data analysis companies, case experts, diagnostic development companies;
III. Exhibition Scope
1. Domestic and International Cell Therapy Institutions
Cell therapy, stem cell and regenerative medicine diagnosis and treatment services, precision medicine services, anti-aging medicine management, medical testing, clinical applications, biological products, etc.
2. Instruments, Equipment, and Consumables
Liquid nitrogen tanks, centrifuges, bioreactors, reagents, culture media, mass spectrometry systems, filtration devices, laboratory cabinets/shakers, etc.
3. Technical Service Solutions
Biochips, flow cytometry, cytokines, cell resistance testing, animal models, cell storage, cold chain transportation, smart factory information technology, etc.
4. Drug Registration Process Development
CROs, CMOs, CSOs, clinical organization, GMP production, protein purification and separation, etc.
5. CMC Process Development and Quality Control
Efficacy evaluation, sterilization/cleaning, sterile laboratories, automated culture equipment, animal serum, high-throughput screening platforms, cell preparations, etc.
6. Organoid Culture and Organ Models
Organ-on-a-Chip R&D, disease models, functional organoids, 3D Bioprinting Technology, Drug Susceptibility Screening, Biomaterials, Nanotechnology, Detection and Imaging Equipment
IV. Agenda
Topic 1: International Cell Therapy Practice and Application
Manufacture and Clinical Trials of hPSc-Based RPE Products for AMD
Japanese Stem Cell Research and Treatment: World-Leading Regenerative Medicine Technology
Latest Treatment Advances from the US NEBULA Project
Biodistribution Studies of Stem Cell Products
Development of Customized Treatment Plans at the German Center for Fresh Cell Therapy (NILCT)
Stem Cell Data Management for Cells Intended for Clinical Use
CLP Diagnostic and Rehabilitation Center in Switzerland: Stem Cell Therapy Plan Evaluation
Establishment and Introduction of Cell Hospitals
Topic 2: Progress and Policy Support for Innovative Cell Therapies in China
Co-building the Upstream and Downstream Supply Chain of TIL Therapy
Progress and Reflections on the Development of Universal CAR-T Cell Technology
Autologous Bone Marrow Cells for the Treatment of Various Diseases
Regulatory Issues for the Generation of Organoids in China
Interpretation of the "Technical Guidelines for Clinical Pharmacology Research of Cell Therapy Products (Trial Implementation)"
Autologous Hematopoietic Stem Cell Transplantation Efficacy and Safety Evaluation in Type 1 Diabetes
Topic 3: Preclinical Research on Cell Therapy Technologies
Optical Molecular Imaging Technology for Cell Therapy and Tracing Research
Precision Biomanufacturing of In Vitro Pathological Models
Dose Optimization Strategies for T Cell-Based Therapy
Detection and Evaluation of Host Immune System Elimination of Transfused Cells
Analysis of Adverse Reactions to Hematopoietic Stem Cell Transplantation
Research Progress on Differences in Biological Properties of Mesenchymal Stem Cells from Different Sources
Topic 4: Clinical Applications and Industrial Transformation of Stem Cells
Clinical Study of Placental Mesenchymal Stem Cell Gel for the Treatment of Radiation-Injured Skin
Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Elderly and Unfit Acute Myeloid Leukemia
Safety and Efficacy of Human Umbilical Cord Mesenchymal Cell Injection for the Treatment of Knee Osteoarthritis
Research on the Relationship between Abnormal Hematopoietic Stem Cell Differentiation and the Pathogenesis of Multiple Myeloma
Strategies for Nonclinical Evaluation of Stem Cell Products
Topic 5: Stem Cells and Regenerative Medicine
Recent International Trends in Stem Cell Regenerative Medicine
Regenerative Medicine Strategies for the Prevention and Treatment of Aging Diseases
Methods for Implementing Stem Cells to Reverse the Aging Process and Efficacy and Mechanism Evaluation Techniques
Clinical Research on Regenerative Islet Transplantation
Mitochondrial Metabolic Checkpoints and Aging and Regeneration of Hematopoietic Stem Cells
Research and Industrialization of Ginseng Stem Cell Regeneration Mechanisms
Topic 6: Stem Cells and Reproductive Health Medicine
Strategies for Improving the Quality of Aged Oocytes
Strategies for Assisted Reproductive Management of Thin Endometrium
Study on HUCMSC-Exos Transplantation for the Treatment of Diabetic ED in Rat Models
Cellular and Life Reprogramming
Application of Stem Cells in the Treatment of Intrauterine Adhesions
The Impact of Mitochondrial Function on Assisted Reproductive Technology
Topic 7: Organoid Drug Development and Precision Medicine
Research on Predicting Personalized Drug Adverse Reactions Using Organoid Models
Optimization and Practice of a High-Throughput Drug Screening Platform Based on Organoids
Developing Novel Gene Therapies Using Organoids Combined with Gene Editing Technologies
Establishing a Precision Drug Screening Platform for Tumor Organoids by Reconstructing the Immune Microenvironment
Co-culture of Intestinal Organoids and the Microbiome to Analyze the Gut Microbiome
Organoid Technology for Simulating the Pathogenesis of Rare Diseases and Exploring Therapeutic Targets
Topic 8: Extracellular Vesicle Research and Clinical Applications
Engineered Human EVs for Tissue Repair and Regeneration
A Small-Scale Clinical Study of the Safety and Preliminary Efficacy of Exosomes in the Treatment of Liver Cirrhosis
Potential Applications of Exosomal RNAs in Diagnostics and Therapeutics
Research on the Mechanisms and Applications of Extracellular Vesicles in Biliary Tract Malignant Tumor Metastasis and Drug Resistance
Characterization, Detection, and Diagnostic Applications of Extracellular Vesicles
Special Topic 9: Stem Cell Exosomes Empower Healthcare
Stem Cells and the Healthcare Industry: Future Development Trends
Applications of Stem Cell Exosomes in Skincare Products
Applications of Stem Cells and Exosomes in Plastic Surgery
Adipose-Derived T Cell Exosomes for the Treatment of Androgenic Alopecia
Surgery for Stem Cell-Engineering Cartilage to Radicalize Cartilage Damage
Phase I Clinical Results of Adipose-Derived Mesenchymal Stem Cell Injection and Prospects for Medical Aesthetic Applications
Special Topic 10: Stem Cells and Chronic Disease Management and Medical Aesthetics
Precision Therapy for Lung Cancer Improves Patient Survival
KMT2D Deficiency Leads to Developmental Impairment and Enhancer Dysregulation in Brain Organs Containing the Neural Coronary
Clinical Trials Using Stem Cell Therapy to Slow or Reverse the Normal Aging Process
Clinical Applications for Anti-Aging in the Female Brain
Regenerative Medicine Utilizing the Characteristics of Placental Exosomes
Safety and Efficacy Evaluation of Stem Cell-Based Anti-Aging Cosmetology
Special Topic 11: Cell Safety and Efficacy Testing and Quality Control
Clinical Research Using Flow Cytometry to Detect Lymphoma Pathological Characteristics
NK Cell Drug Development Progress and Process Development Strategies
Application of Generative AI in Clinical Development
Experience and Solutions for Innovative Drug Clinical Development Strategies
Application of Cytokines in Immunotherapy
High-Throughput Drug Screening Empowers New Drug Development
Special Topic 12: Cell Therapy Drug Development and Clinical Application
New Drug Progress for Hematological Malignancies: Bispecific T Cell Engagers
CMC Development Strategies and Challenges of iPSC-Derived Cell Therapies for Degenerative and Injurious Neurological Diseases
iPSC (Induced Pluripotent Stem Cell)-Derived Cell Drug Development
Prospects and Challenges of Universal, Off-the-Shelf iPSC-Derived CAR-NK Therapies
Development of Innovative Cell Therapies for Solid Tumors
New Hope for Diabetes: Pharmaceutical Research on Stem Cell-Induced B Cells for Diabetes
